Literature DB >> 15157801

Effects of triflusal on oxidative stress, prostaglandin production and nitric oxide pathway in a model of anoxia-reoxygenation in rat brain slices.

J A González-Correa1, M M Arrebola, I M Ureña, A Guerrero, J Muñoz-Marín, D Ruiz-Villafranca, F Sánchez De La Cuesta, J P De La Cruz.   

Abstract

Acetylsalicylic acid (ASA) is the most widely used drug in the prevention of ischemic vascular accidents, mainly because of its antithrombotic effect. Recently, evidence of a neuroprotective effect has appeared. The aim of this study was to evaluate the neuroprotective effect of triflusal, a fluorinated derivative of ASA, in a model of anoxia-reoxygenation in rat brain slices. Rats (n=10 per group) were treated for 7 days with 1, 10 or 50 mg/kg/day p.o. of triflusal or ASA or solvent (control group), then brain slices were obtained and subjected to a period of anoxia followed by 180 min of reoxygenation. We measured oxidative stress parameters (lipid peroxidation, glutathione system), prostaglandins (PGE(2)), nitric oxide pathway activity (NO) (nitrites+nitrates, constitutive and inducible NO synthase activity) and cell death (lactate dehydrogenase (LDH) efflux). Triflusal decreased cell death in rat brain slices subjected to reoxygenation after anoxia by 21%, 42% and 47% with 1, 10 and 50 mg/kg/day, respectively. This effect was proportionately greater than the effect of ASA (0%, 25% and 24%). The antioxidant effects of triflusal on the biochemical mechanisms of cell damage studied here were also greater than the effects of ASA: lipid peroxidation was reduced by 29%, 35% and 36% with triflusal, and 0%, 19% and 29% with ASA. Inducible NO synthase activity was reduced by 25%, 27% and 30% with triflusal, and 0%, 25% and 24% with ASA. Triflusal can be considered an alternative to ASA as a neuroprotective agent, at least in the experimental model of anoxia-reoxygenation used in the present study. Copyright 2004 Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15157801     DOI: 10.1016/j.brainres.2004.02.069

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  4 in total

Review 1.  Triflusal: a review of its use in cerebral infarction and myocardial infarction, and as thromboprophylaxis in atrial fibrillation.

Authors:  David Murdoch; Greg L Plosker
Journal:  Drugs       Date:  2006       Impact factor: 9.546

2.  Lack of enantiomeric influence on the brain cytoprotective effect of ibuprofen and flurbiprofen.

Authors:  J A López-Villodres; J P De La Cruz; J Muñoz-Marin; A Guerrero; J J Reyes; J A González-Correa
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-06-29       Impact factor: 3.000

3.  Protective effect of triflusal and its main metabolite HTB in an in vitro model of anoxia-reoxygenation in rat brain slices: comparison with acetylsalicylic and salicylic acids.

Authors:  J A González-Correa; M M Arrebola; I M Ureña; D Ruiz-Villafranca; J Muñoz-Marín; A Guerrero; F Sánchez de la Cuesta; J P De La Cruz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-12-16       Impact factor: 3.000

4.  Prostaglandin transporter expression in mouse brain during development and in response to hypoxia.

Authors:  S Scafidi; R M Douglas; R Farahani; K J Banasiak; G G Haddad
Journal:  Neuroscience       Date:  2007-04-11       Impact factor: 3.590

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.